Elke Schultz-Thater
Overview
Explore the profile of Elke Schultz-Thater including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zajac P, Schultz-Thater E, Tornillo L, Sadowski C, Trella E, Mengus C, et al.
Front Med (Lausanne)
. 2017 Mar;
4:18.
PMID: 28337438
MAGE-A antigens are expressed in a variety of cancers of diverse histological origin and germinal cells. Due to their relatively high tumor specificity, they represent attractive targets for active specific...
2.
Hirt C, Papadimitropoulos A, Muraro M, Mele V, Panopoulos E, Cremonesi E, et al.
Biomaterials
. 2015 Jun;
62:138-46.
PMID: 26051518
Anticancer compound screening on 2D cell cultures poorly predicts "in vivo" performance, while conventional 3D culture systems are usually characterized by limited cell proliferation, failing to produce tissue-like-structures (TLS) suitable...
3.
Bhattacharjee M, Schultz-Thater E, Trella E, Miot S, Das S, Loparic M, et al.
Biomaterials
. 2013 Jul;
34(33):8161-71.
PMID: 23896003
We have investigated monocyte and T cell responsiveness to silk based biomaterials of different physico-chemical characteristics. Here we report that untransformed CD14+ human monocytes respond to overnight exposure to silk...
4.
Mengus C, Schultz-Thater E, Coulot J, Kastelan Z, Goluza E, Coric M, et al.
Int J Cancer
. 2012 Nov;
132(10):2459-63.
PMID: 23125074
Bladder cancer is a common urinary malignancy and a prevalent cause of cancer-related death. Current therapies of early stage non-muscle-invasive bladder cancer (NMIBC) are frequently associated with undesirable toxicities and...
5.
Schultz-Thater E, Piscuoglio S, Iezzi G, Le Magnen C, Zajac P, Carafa V, et al.
Int J Cancer
. 2011 Jun;
129(5):1137-48.
PMID: 21710496
MAGE-A10 is a highly immunogenic member of the MAGE-A family of cancer/testis tumor-associated antigens (C/T TAAs). Studies performed with broadly reactive antibodies have helped to initially characterize this TAA. However,...
6.
Sconocchia G, Spagnoli G, Del Principe D, Ferrone S, Anselmi M, Wongsena W, et al.
Neoplasia
. 2009 Jul;
11(7):662-71.
PMID: 19568411
We have explored MICA/B expression and its relationship with innate inflammatory infiltrate in renal cell carcinoma (RCC). The expression of MICA/B, CD16, CD56, and CD68 in 140 RCC lesions contained...
7.
Schaeren S, Jaquiery C, Wolf F, Papadimitropoulos A, Barbero A, Schultz-Thater E, et al.
J Biomed Mater Res A
. 2009 Apr;
92(4):1461-7.
PMID: 19402137
In this study, we addressed whether Bone Sialoprotein (BSP) coating of various substrates could enhance the in vitro osteogenic differentiation and in vivo bone formation capacity of human Bone Marrow...
8.
Schultz-Thater E, Frey D, Margelli D, Raafat N, Feder-Mengus C, Spagnoli G, et al.
J Transl Med
. 2008 Oct;
6:58.
PMID: 18925935
Background: Monitoring of cellular immune responses is indispensable in a number of clinical research areas, including microbiology, virology, oncology and autoimmunity. Purification and culture of peripheral blood mononuclear cells and...
9.
Feder-Mengus C, Schultz-Thater E, Oertli D, Marti W, Heberer M, Spagnoli G, et al.
Hum Gene Ther
. 2005 Apr;
16(3):348-60.
PMID: 15812230
Recombinant poxviruses expressing immunomodulatory molecules together with specific antigens represent powerful vaccines for cancer immunotherapy. Recently, we and others have demonstrated, in vitro and in vivo, that coexpression of CD80...
10.
Bolli M, Schultz-Thater E, Zajac P, Guller U, Feder C, Sanguedolce F, et al.
Int J Cancer
. 2005 Mar;
115(6):960-6.
PMID: 15751033
The characterization of the expression pattern of different families of cancer/testis (C/T) antigens in different tumors, at the protein level, might be of relevance in the development of multiantigen vaccine...